Analysts Are Neutral on These Healthcare Stocks: SAGE Therapeutics (SAGE), Adverum Biotechnologies (ADVM)
TipRanksMar 27 21:50 ET
Adverum Biotechnologies Analyst Ratings
BenzingaMar 19 08:52 ET
Chardan Capital Reiterates Buy on Adverum Biotechnologies, Maintains $4 Price Target
BenzingaMar 19 08:54 ET
Adverum Biotechnologies Analyst Ratings
BenzingaMar 19 08:12 ET
RBC Capital Maintains Sector Perform on Adverum Biotechnologies, Lowers Price Target to $2
BenzingaMar 19 08:13 ET
RBC Cuts Price Target on Adverum Biotechnologies to $2 From $3, Keeps Sector Perform, Speculative Risk
MT NewswiresMar 19 07:09 ET
Adverum Biotechnologies (ADVM) Initiated With a Hold at RBC Capital
TipRanksMar 19 06:45 ET
Adverum Biotechnologies (ADVM) Receives a Buy From TD Cowen
TipRanksMar 18 17:55 ET
Adverum Biotechnologies Analyst Ratings
BenzingaFeb 6 14:15 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Healthequity (HQY), Adverum Biotechnologies (ADVM) and Edwards Lifesciences (EW)
TipRanksFeb 5 04:50 ET
Analysts Offer Insights on Healthcare Companies: InMode (INMD), Ocular Therapeutix (OCUL) and Adverum Biotechnologies (ADVM)
TipRanksDec 11, 2023 02:20 ET
Promising Developments in Adverum Biotechnologies' Gene Therapy Candidate, Ixo-Vec, Drive Graig Suvannavejh's Bullish Rating
TipRanksNov 20, 2023 02:05 ET
Truist Financial Remains a Buy on Adverum Biotechnologies (ADVM)
TipRanksNov 16, 2023 21:25 ET
Analysts Conflicted on These Healthcare Names: Xenon (XENE), Adverum Biotechnologies (ADVM) and 4D Molecular Therapeutics (FDMT)
TipRanksNov 10, 2023 20:50 ET
RBC Capital Reaffirms Their Hold Rating on Adverum Biotechnologies (ADVM)
TipRanksNov 10, 2023 20:50 ET
Adverum Biotechnologies' Potential Outperformance: A Buy Rating Based on Ixo-Vec Progress and OPTIC Study Results
TipRanksNov 9, 2023 20:06 ET
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Adverum Biotechnologies (ADVM) and Alignment Healthcare (ALHC)
TipRanksNov 8, 2023 00:51 ET
Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), IGM Biosciences (IGMS) and Adverum Biotechnologies (ADVM)
TipRanksSep 6, 2023 22:30 ET
Truist Securities Reiterates Buy on Adverum Biotechnologies, Maintains $6 Price Target
BenzingaSep 5, 2023 10:03 ET
Adverum Biotechnologies Analyst Ratings
BenzingaSep 5, 2023 10:02 ET
No Data
No Data